Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€5.92
09.08.21
-
09.08.22
-41.72%
10.08.22

Probably not worthwhile Investment
Below average Marketposition
Higher risks for its business
Lokrim 
09.08.21 20%
buy
Innoviva Inc.

Start price
Target price
Perf. (%)
€13.00
06.08.21
-
06.08.22
28.46%
02.03.22

GMSE 
06.08.21 50%
buy
MPH Health Care AG

Start price
Target price
Perf. (%)
€27.00
06.08.21
-
06.08.22
-38.33%
06.08.22

Erntehelfer 
06.08.21 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€9.95
05.08.21
-
05.08.22
23.44%
08.08.21

Could be worthwhile Investment >10% per year
Vassago1 
05.08.21 50%
sell
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€12.50
30.07.21
€10.00
30.07.22
142.00%
13.10.21

Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
geldnutzer 
30.07.21 60%
sell
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€5.10
30.07.21
-
30.07.22
2.55%
08.08.21

Risky Investment
Vassago1 
30.07.21 50%
buy
Infinity Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.38
29.07.21
-
28.07.22
-72.64%
29.07.22

Probably not worthwhile Investment
High valuation
Revenue decline/stagnation expected
Sustainability is little important
Amped 
29.07.21 0%
sell
Infinity Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.92
28.07.21
-
28.07.22
-25.00%
06.01.22

Probably not worthwhile Investment
High valuation
tinelchen 
28.07.21 0%
sell
Infinity Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.76
28.07.21
-
28.07.22
35.23%
29.07.21

Probably not worthwhile Investment
High valuation
Revenue decline/stagnation expected
Sustainability is little important
Amped 
28.07.21 0%
buy
Harvard Bioscience

Start price
Target price
Perf. (%)
€6.50
27.07.21
-
27.07.22
-25.54%
02.03.22

GMSE 
27.07.21 50%
sell
Ardelyx Inc.

Start price
Target price
Perf. (%)
€1.32
26.07.21
-
26.07.22
-48.82%
27.07.22

Risky Investment
Lokrim 
26.07.21 10%
buy
Trinity Biotech ADR

Start price
Target price
Perf. (%)
€1.66
26.07.21
-
26.07.22
-21.08%
27.07.22

Could be very worthwhile Investment >20% year
skyrockerZoe 
26.07.21 0%
buy
Castlight Healt.b

Start price
Target price
Perf. (%)
€1.85
23.07.21
-
23.07.22
-4.32%
02.03.22

GMSE 
23.07.21 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€11.24
20.07.21
€20.00
20.07.22
116.90%
25.11.21

Could be worthwhile Investment >10% per year
Very valuable balance sheet
melinda 
20.07.21 50%
buy
Stratec SE

Start price
Target price
Perf. (%)
€121.80
20.07.21
€135.00
20.07.22
4.76%
30.07.21

Risky Investment
Traumtanz 
20.07.21 50%
buy
Trupanion Inc.

Start price
Target price
Perf. (%)
€87.08
18.07.21
-
18.07.22
-27.35%
18.07.22

Saftman 
18.07.21 50%
buy
Paul Hartmann AG

Start price
Target price
Perf. (%)
€360.00
14.07.21
€450.00
14.07.22
0.28%
24.07.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
Covacoro 
14.07.21 70%
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€14.10
13.07.21
€21.00
13.07.22
-10.78%
13.08.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
dimontalban 
13.07.21 80%
sell
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€13.66
13.07.21
-
13.07.22
69.13%
14.07.22

Could be worthwhile Investment >10% per year
Standard Investments for future growth
Sustainability is important
High valuation
Amped 
13.07.21 0%
buy
Biolife Solutions Inc

Start price
Target price
Perf. (%)
€40.84
13.07.21
-
13.07.22
-62.81%
13.07.22

Saftman 
13.07.21 50%
buy
Catalyst Pharmaceutical Partners Inc

Start price
Target price
Perf. (%)
€4.66
12.07.21
-
12.07.22
48.95%
13.03.22

Kilianhammernick 
12.07.21 50%
sell
Inovio Pharma

Start price
Target price
Perf. (%)
€6.92
10.07.21
€5.80
10.07.22
-6.86%
27.11.21

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
10.07.21 50%
sell
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€1.28
10.07.21
€0.80
10.07.22
-30.80%
20.12.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
geldnutzer 
10.07.21 50%
sell
CareCloud Inc.

Start price
Target price
Perf. (%)
€6.85
10.07.21
€3.20
10.07.22
-46.86%
11.07.22

Growths slower than the competition
Below average Marketposition
Revenue decline/stagnation expected
EBIT decline/stagnation expected
geldnutzer 
10.07.21 50%
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€14.32
10.07.21
€20.00
10.07.22
-12.71%
30.07.21

Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
geldnutzer 
10.07.21 60%